Division of Oncology, Oncology Imperial College London, London, United Kingdom.
Cancer Res. 2013 Sep 1;73(17):5301-8. doi: 10.1158/0008-5472.CAN-12-4448. Epub 2013 Aug 22.
The p90 ribosomal S6 kinases (RSK) are implicated in various cellular processes, including cell proliferation, survival, migration, and invasion. In cancer, RSKs modulate cell transformation, tumorigenesis, and metastasis. Indeed, changes in the expression of RSK isoforms have been reported in several malignancies, including breast, prostate, and lung cancers. Four RSK isoforms have been identified in humans on the basis of their high degree of sequence homology. Although this similarity suggests some functional redundancy between these proteins, an increasing body of evidence supports the existence of isoform-based specificity among RSKs in mediating particular cellular processes. This review briefly presents the similarities between RSK family members before focusing on the specific function of each of the isoforms and their involvement in cancer progression.
p90 核糖体 S6 激酶(RSK)参与多种细胞过程,包括细胞增殖、存活、迁移和侵袭。在癌症中,RSK 调节细胞转化、肿瘤发生和转移。事实上,几种恶性肿瘤中已报道 RSK 同工型的表达变化,包括乳腺癌、前列腺癌和肺癌。根据其高度序列同源性,在人类中已鉴定出 4 种 RSK 同工型。尽管这种相似性表明这些蛋白质之间存在一定程度的功能冗余,但越来越多的证据支持 RSK 在介导特定细胞过程中存在基于同工型的特异性。本综述简要介绍了 RSK 家族成员之间的相似性,然后重点介绍了每种同工型的特定功能及其在癌症进展中的参与。